Ben R. Taylor, CFO of Recursion Pharmaceuticals RXRX, has filed 0 purchases and 3 sales on the open market. Over the past 12 months that comes to a net sale of $157.7K. The latest trade was on 06/15.

BT

BT

Ben R. Taylor

CFO

Company

Recursion Pharmaceuticals RXRX

First filing

24/12/20

Trades

29 trades

Buys / sales

0 / 3

12-month net buying

−$157.7K

Last trade

06/15

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	03/17	03/18	7,956 sh	$3.39	$26,970.84	−0.7%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	02/18	02/19	13,426 sh	$3.08	$41,352.08	−1.1%
Recursion PharmaceuticalsRXRX	Open-market sale10b5-1 plan	25/12/29	25/12/30	21,383 sh	$4.18	$89,380.94	−2.7%